Comparison of Viscoped and PORON for painful submetatarsal hyperkeratotic lesions

MA Caselli Department of Orthopedic Sciences, New York College of Podiatric Medicine, New York, USA.

Search for other papers by MA Caselli in
Current site
Google Scholar
PubMed
Close
,
SJ Levitz Department of Orthopedic Sciences, New York College of Podiatric Medicine, New York, USA.

Search for other papers by SJ Levitz in
Current site
Google Scholar
PubMed
Close
,
N Clark Department of Orthopedic Sciences, New York College of Podiatric Medicine, New York, USA.

Search for other papers by N Clark in
Current site
Google Scholar
PubMed
Close
,
S Lazarus Department of Orthopedic Sciences, New York College of Podiatric Medicine, New York, USA.

Search for other papers by S Lazarus in
Current site
Google Scholar
PubMed
Close
,
Z Velez Department of Orthopedic Sciences, New York College of Podiatric Medicine, New York, USA.

Search for other papers by Z Velez in
Current site
Google Scholar
PubMed
Close
, and
L Venegas Department of Orthopedic Sciences, New York College of Podiatric Medicine, New York, USA.

Search for other papers by L Venegas in
Current site
Google Scholar
PubMed
Close

A clinical study was performed to evaluate the efficacy of the Viscoped Insole as compared with an 1/8-inch PORON medical materials insole in the treatment of lesser submetatarsal hyperkeratotic callosities. Thirty-five patients, ranging in age from 23 through 61 years (average 42 years) were randomly divided into three groups. All three groups initially had debridement of their submetatarsal callosities. In addition to the debridement, the first group (16 patients) wore a Viscoped Insole for 4 weeks. The patients in the second group wore a PORON insole for 4 weeks. The third group did not receive an insole after their debridement and served as the control. There was a significant improvement in the Viscoped group and the PORON group versus the control group (x2 = 40; p < 0.01) as measured by the foot function index. Insole therapy combined with debridement for submetatarsal hyperkeratoses is more effective than debridement alone.

Save